Signatures of mutational processes in human cancer

Ludmil B Alexandrov1, Serena Nik-Zainal, David C Wedge

  • 1Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Nature
|August 16, 2013
PubMed

Insights

Cancer development is driven by somatic mutations. This study identified over 20 distinct mutational signatures across 7,042 cancers, revealing diverse biological processes and potential therapeutic targets.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Somatic mutations are the fundamental cause of all cancers.
  • Understanding the biological processes that generate these mutations is crucial but limited.
  • Cancer genomes contain signatures reflecting the mutational processes involved.

Purpose of the Study:

  • To analyze a large dataset of cancer mutations to identify and characterize mutational signatures.
  • To explore the origins and associations of these signatures with clinical and etiological factors.
  • To investigate localized hypermutation events ('kataegis') in cancer genomes.

Main Methods:

  • Analysis of 4,938,362 mutations from 7,042 cancer samples.
  • Extraction and classification of distinct mutational signatures.
  • Correlation of signatures with patient age, mutagenic exposures, and DNA repair defects.

Main Results:

  • Identification of over 20 distinct mutational signatures.
  • Discovery of signatures associated with APOBEC enzymes, patient age, and DNA maintenance.
  • Observation of cryptic signatures and localized hypermutation (kataegis) in various cancer types.
  • Demonstration of diverse mutational processes underlying cancer development.

Conclusions:

  • The study reveals a wide spectrum of mutational processes contributing to cancer.
  • Mutational signatures offer insights into cancer etiology, prevention, and treatment strategies.
  • Further research into cryptic signatures and kataegis could uncover novel therapeutic avenues.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...